ID   KALRN_HUMAN             Reviewed;        2986 AA.
AC   O60229; A8MSI4; C9JQ37; J3QSW6; Q6ZN45; Q8TBQ5; Q9NSZ4; Q9Y2A5;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   31-JUL-2019, sequence version 3.
DT   03-AUG-2022, entry version 211.
DE   RecName: Full=Kalirin {ECO:0000250|UniProtKB:P97924};
DE            EC=2.7.11.1;
DE   AltName: Full=Huntingtin-associated protein-interacting protein;
DE   AltName: Full=Protein Duo;
DE   AltName: Full=Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain;
GN   Name=KALRN {ECO:0000312|HGNC:HGNC:4814};
GN   Synonyms=DUET, DUO, HAPIP, TRAD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Frontal cortex;
RX   PubMed=9285789; DOI=10.1093/hmg/6.9.1519;
RA   Colomer V., Engelender S., Sharp A.H., Duan K., Cooper J.K., Lanahan A.,
RA   Lyford G., Worley P., Ross C.A.;
RT   "Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide,
RT   with a rac1 guanine nucleotide exchange factor domain.";
RL   Hum. Mol. Genet. 6:1519-1525(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), FUNCTION, MUTAGENESIS OF LYS-2713,
RP   AUTOPHOSPHORYLATION, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   TISSUE=Skeletal muscle;
RX   PubMed=10023074; DOI=10.1016/s0378-1119(98)00605-2;
RA   Kawai T., Sanjo H., Akira S.;
RT   "Duet is a novel serine/threonine kinase with Dbl-homology (DH) and
RT   pleckstrin-homology (PH) domains.";
RL   Gene 227:249-255(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 641-1464 (ISOFORM 1).
RC   TISSUE=Amygdala, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1917 (ISOFORM 6), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2105-2986 (ISOFORM 5).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2017-2986 (ISOFORM 5).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1750; SER-1753; SER-1799;
RP   SER-1817 AND SER-2262, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1799, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   INTERACTION WITH FASLG.
RX   PubMed=19807924; DOI=10.1186/1471-2172-10-53;
RA   Voss M., Lettau M., Janssen O.;
RT   "Identification of SH3 domain interaction partners of human FasL (CD178) by
RT   phage display screening.";
RL   BMC Immunol. 10:53-53(2009).
RN   [11]
RP   SPECTRIN REPEATS.
RX   PubMed=22738176; DOI=10.1021/bi300583s;
RA   Vishwanatha K.S., Wang Y.P., Keutmann H.T., Mains R.E., Eipper B.A.;
RT   "Structural organization of the nine spectrin repeats of Kalirin.";
RL   Biochemistry 51:5663-5673(2012).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] TRP-213 AND CYS-1897.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [13]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-196.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Promotes the exchange of GDP by GTP. Activates specific Rho
CC       GTPase family members, thereby inducing various signaling mechanisms
CC       that regulate neuronal shape, growth, and plasticity, through their
CC       effects on the actin cytoskeleton. Induces lamellipodia independent of
CC       its GEF activity. {ECO:0000269|PubMed:10023074}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- SUBUNIT: Interacts with the C-terminal of peptidylglycine alpha-
CC       amidating monooxygenase (PAM) and with the huntingtin-associated
CC       protein 1 (HAP1) (By similarity). Interacts with FASLG. {ECO:0000250,
CC       ECO:0000269|PubMed:19807924}.
CC   -!- INTERACTION:
CC       O60229; PRO_0000449631 [P0DTD1]: rep; Xeno; NbExp=3; IntAct=EBI-949233, EBI-25475920;
CC       O60229; PRO_0000449633 [P0DTD1]: rep; Xeno; NbExp=3; IntAct=EBI-949233, EBI-25492395;
CC       O60229-2; Q9Y6H5-1: SNCAIP; NbExp=3; IntAct=EBI-9075360, EBI-9075374;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10023074}.
CC       Cytoplasm, cytoskeleton {ECO:0000269|PubMed:10023074}. Note=Associated
CC       with the cytoskeleton.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O60229-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60229-2; Sequence=VSP_028910, VSP_028911;
CC       Name=4; Synonyms=DUET, TRAD;
CC         IsoId=O60229-4; Sequence=VSP_028903, VSP_028912;
CC       Name=5;
CC         IsoId=O60229-5; Sequence=VSP_028904, VSP_028909, VSP_028913,
CC                                  VSP_028914, VSP_028915;
CC       Name=6;
CC         IsoId=O60229-6; Sequence=VSP_028903, VSP_028912, VSP_028913;
CC   -!- TISSUE SPECIFICITY: Isoform 2 is brain specific. Highly expressed in
CC       cerebral cortex, putamen, amygdala, hippocampus and caudate nucleus.
CC       Weakly expressed in brain stem and cerebellum. Isoform 4 is expressed
CC       in skeletal muscle. {ECO:0000269|PubMed:10023074}.
CC   -!- DOMAIN: The two GEF domains catalyze nucleotide exchange for RAC1 and
CC       RhoA which are bound by DH1 and DH2 respectively. The two GEF domains
CC       appear to play differing roles in neuronal development and axonal
CC       outgrowth. SH3 1 binds to the first GEF domain inhibiting GEF activity
CC       only when in the presence of a PXXP peptide, suggesting that the SH3
CC       domain/peptide interaction mediates binding to GEF1. CRK1 SH3 domain
CC       binds to and inhibits GEF1 activity (By similarity). {ECO:0000250}.
CC   -!- PTM: Autophosphorylated.
CC   -!- MISCELLANEOUS: Called DUO because the encoded protein is closely
CC       related to but shorter than TRIO.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH58015.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAD18530.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U94190; AAC15791.1; -; mRNA.
DR   EMBL; AB011422; BAA76314.1; -; mRNA.
DR   EMBL; AK125979; BAC86373.1; -; mRNA.
DR   EMBL; AK131379; BAD18530.1; ALT_SEQ; mRNA.
DR   EMBL; AC022336; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC069233; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC080008; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC112129; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117401; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF457679; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW79410.1; -; Genomic_DNA.
DR   EMBL; BC026865; AAH26865.1; -; mRNA.
DR   EMBL; BC058015; AAH58015.1; ALT_SEQ; mRNA.
DR   EMBL; AL137629; CAB70850.1; -; mRNA.
DR   CCDS; CCDS3027.1; -. [O60229-2]
DR   CCDS; CCDS3028.1; -. [O60229-4]
DR   PIR; T46482; T46482.
DR   RefSeq; NP_001019831.2; NM_001024660.4. [O60229-1]
DR   RefSeq; NP_001309917.1; NM_001322988.1.
DR   RefSeq; NP_001309918.1; NM_001322989.1.
DR   RefSeq; NP_001309923.1; NM_001322994.1.
DR   RefSeq; NP_001309924.1; NM_001322995.1.
DR   RefSeq; NP_001309925.1; NM_001322996.1.
DR   RefSeq; NP_001309926.1; NM_001322997.1.
DR   RefSeq; NP_001309927.1; NM_001322998.1.
DR   RefSeq; NP_001309928.1; NM_001322999.1.
DR   RefSeq; NP_001309929.1; NM_001323000.1.
DR   RefSeq; NP_001309930.1; NM_001323001.1.
DR   RefSeq; NP_003938.1; NM_003947.5. [O60229-2]
DR   RefSeq; NP_008995.2; NM_007064.4. [O60229-4]
DR   PDB; 5QQD; X-ray; 1.91 A; B=1280-1459.
DR   PDB; 5QQE; X-ray; 1.95 A; B=1280-1459.
DR   PDB; 5QQF; X-ray; 2.26 A; B=1280-1459.
DR   PDB; 5QQG; X-ray; 2.23 A; B=1280-1459.
DR   PDB; 5QQH; X-ray; 2.09 A; B=1280-1459.
DR   PDB; 5QQI; X-ray; 2.08 A; B=1280-1459.
DR   PDB; 5QQJ; X-ray; 1.90 A; B=1280-1459.
DR   PDB; 5QQK; X-ray; 2.24 A; B=1280-1459.
DR   PDB; 5QQL; X-ray; 2.25 A; B=1280-1459.
DR   PDB; 5QQM; X-ray; 2.02 A; B=1280-1459.
DR   PDB; 5QQN; X-ray; 2.26 A; B=1280-1459.
DR   PDB; 5QU9; X-ray; 2.00 A; B=1280-1459.
DR   PDBsum; 5QQD; -.
DR   PDBsum; 5QQE; -.
DR   PDBsum; 5QQF; -.
DR   PDBsum; 5QQG; -.
DR   PDBsum; 5QQH; -.
DR   PDBsum; 5QQI; -.
DR   PDBsum; 5QQJ; -.
DR   PDBsum; 5QQK; -.
DR   PDBsum; 5QQL; -.
DR   PDBsum; 5QQM; -.
DR   PDBsum; 5QQN; -.
DR   PDBsum; 5QU9; -.
DR   SMR; O60229; -.
DR   BioGRID; 114478; 26.
DR   IntAct; O60229; 19.
DR   MINT; O60229; -.
DR   STRING; 9606.ENSP00000240874; -.
DR   iPTMnet; O60229; -.
DR   PhosphoSitePlus; O60229; -.
DR   SwissPalm; O60229; -.
DR   BioMuta; KALRN; -.
DR   EPD; O60229; -.
DR   jPOST; O60229; -.
DR   MassIVE; O60229; -.
DR   MaxQB; O60229; -.
DR   PaxDb; O60229; -.
DR   PeptideAtlas; O60229; -.
DR   PRIDE; O60229; -.
DR   ProteomicsDB; 11196; -.
DR   ProteomicsDB; 49252; -. [O60229-1]
DR   ProteomicsDB; 49253; -. [O60229-2]
DR   ProteomicsDB; 49255; -. [O60229-4]
DR   ProteomicsDB; 49256; -. [O60229-5]
DR   ProteomicsDB; 49257; -. [O60229-6]
DR   Antibodypedia; 2142; 177 antibodies from 33 providers.
DR   DNASU; 8997; -.
DR   Ensembl; ENST00000240874.7; ENSP00000240874.3; ENSG00000160145.16. [O60229-2]
DR   Ensembl; ENST00000291478.9; ENSP00000291478.4; ENSG00000160145.16. [O60229-4]
DR   Ensembl; ENST00000360013.7; ENSP00000353109.3; ENSG00000160145.16. [O60229-1]
DR   GeneID; 8997; -.
DR   KEGG; hsa:8997; -.
DR   UCSC; uc003ehf.2; human. [O60229-1]
DR   CTD; 8997; -.
DR   DisGeNET; 8997; -.
DR   GeneCards; KALRN; -.
DR   HGNC; HGNC:4814; KALRN.
DR   HPA; ENSG00000160145; Tissue enhanced (brain).
DR   MalaCards; KALRN; -.
DR   MIM; 604605; gene.
DR   neXtProt; NX_O60229; -.
DR   OpenTargets; ENSG00000160145; -.
DR   PharmGKB; PA29189; -.
DR   VEuPathDB; HostDB:ENSG00000160145; -.
DR   eggNOG; KOG4240; Eukaryota.
DR   GeneTree; ENSGT00940000155248; -.
DR   HOGENOM; CLU_000373_0_1_1; -.
DR   InParanoid; O60229; -.
DR   OMA; AKXFIMA; -.
DR   OrthoDB; 5761at2759; -.
DR   PhylomeDB; O60229; -.
DR   TreeFam; TF318080; -.
DR   PathwayCommons; O60229; -.
DR   Reactome; R-HSA-193648; NRAGE signals death through JNK.
DR   Reactome; R-HSA-3928662; EPHB-mediated forward signaling.
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   Reactome; R-HSA-416482; G alpha (12/13) signalling events.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-8980692; RHOA GTPase cycle.
DR   Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR   Reactome; R-HSA-9013408; RHOG GTPase cycle.
DR   SignaLink; O60229; -.
DR   SIGNOR; O60229; -.
DR   BioGRID-ORCS; 8997; 10 hits in 1108 CRISPR screens.
DR   ChiTaRS; KALRN; human.
DR   GeneWiki; Kalirin; -.
DR   GenomeRNAi; 8997; -.
DR   Pharos; O60229; Tbio.
DR   PRO; PR:O60229; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; O60229; protein.
DR   Bgee; ENSG00000160145; Expressed in secondary oocyte and 165 other tissues.
DR   ExpressionAtlas; O60229; baseline and differential.
DR   Genevisible; O60229; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; TAS:ProtInc.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0019898; C:extrinsic component of membrane; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0014069; C:postsynaptic density; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; EXP:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0007411; P:axon guidance; IBA:GO_Central.
DR   GO; GO:0007417; P:central nervous system development; IEA:InterPro.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0035556; P:intracellular signal transduction; ISS:HGNC-UCL.
DR   GO; GO:0007399; P:nervous system development; ISS:HGNC-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0016192; P:vesicle-mediated transport; TAS:ProtInc.
DR   CDD; cd00063; FN3; 1.
DR   CDD; cd00160; RhoGEF; 2.
DR   CDD; cd00170; SEC14; 1.
DR   CDD; cd00176; SPEC; 4.
DR   Gene3D; 1.20.900.10; -; 2.
DR   Gene3D; 2.30.29.30; -; 2.
DR   Gene3D; 2.60.40.10; -; 2.
DR   Gene3D; 3.40.525.10; -; 1.
DR   InterPro; IPR001251; CRAL-TRIO_dom.
DR   InterPro; IPR036865; CRAL-TRIO_dom_sf.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR028570; Kalirin/TRIO.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR018159; Spectrin/alpha-actinin.
DR   InterPro; IPR002017; Spectrin_repeat.
DR   PANTHER; PTHR22826:SF104; PTHR22826:SF104; 2.
DR   Pfam; PF13716; CRAL_TRIO_2; 1.
DR   Pfam; PF00041; fn3; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00621; RhoGEF; 2.
DR   Pfam; PF00435; Spectrin; 4.
DR   SMART; SM00060; FN3; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SMART; SM00233; PH; 2.
DR   SMART; SM00325; RhoGEF; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SMART; SM00516; SEC14; 1.
DR   SMART; SM00326; SH3; 2.
DR   SMART; SM00150; SPEC; 7.
DR   SUPFAM; SSF48065; SSF48065; 2.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   SUPFAM; SSF50044; SSF50044; 2.
DR   SUPFAM; SSF52087; SSF52087; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50191; CRAL_TRIO; 1.
DR   PROSITE; PS50010; DH_2; 2.
DR   PROSITE; PS50853; FN3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50002; SH3; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cytoplasm; Cytoskeleton;
KW   Disulfide bond; Guanine-nucleotide releasing factor; Immunoglobulin domain;
KW   Kinase; Magnesium; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Repeat; Serine/threonine-protein kinase; SH3 domain;
KW   Transferase.
FT   CHAIN           1..2986
FT                   /note="Kalirin"
FT                   /id="PRO_0000080955"
FT   DOMAIN          35..180
FT                   /note="CRAL-TRIO"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00056"
FT   REPEAT          167..308
FT                   /note="Spectrin 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          310..417
FT                   /note="Spectrin 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          418..535
FT                   /note="Spectrin 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          536..639
FT                   /note="Spectrin 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          640..770
FT                   /note="Spectrin 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          771..888
FT                   /note="Spectrin 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          889..1004
FT                   /note="Spectrin 7"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1005..1128
FT                   /note="Spectrin 8"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1129..1234
FT                   /note="Spectrin 9"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          1281..1456
FT                   /note="DH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          1468..1580
FT                   /note="PH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          1646..1711
FT                   /note="SH3 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          1929..2104
FT                   /note="DH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          2116..2226
FT                   /note="PH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          2321..2386
FT                   /note="SH3 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          2471..2564
FT                   /note="Ig-like C2-type"
FT   DOMAIN          2571..2665
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          2684..2938
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          710..735
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1594..1642
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1750..1857
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2244..2310
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2412..2454
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        721..735
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1617..1642
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1750..1773
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1782..1804
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1813..1837
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2286..2300
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2412..2434
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        2803
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         2690..2698
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         2713
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   MOD_RES         1750
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18088087"
FT   MOD_RES         1753
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18088087"
FT   MOD_RES         1799
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18088087,
FT                   ECO:0007744|PubMed:18669648"
FT   MOD_RES         1812
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P97924"
FT   MOD_RES         1817
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18088087"
FT   MOD_RES         1913
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:A2CG49"
FT   MOD_RES         2262
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18088087"
FT   DISULFID        2492..2548
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         1..1697
FT                   /note="Missing (in isoform 4 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:10023074"
FT                   /id="VSP_028903"
FT   VAR_SEQ         1..1627
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005"
FT                   /id="VSP_028904"
FT   VAR_SEQ         1628..1643
FT                   /note="ISIASRTSQNTVDSDK -> MLKWISWRQSKANKAQ (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005"
FT                   /id="VSP_028909"
FT   VAR_SEQ         1644..1663
FT                   /note="LSGGCELTVVLQDFSAGHSS -> DGNLVPRWHLGPGDPFSTYV (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9285789"
FT                   /id="VSP_028910"
FT   VAR_SEQ         1664..2986
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9285789"
FT                   /id="VSP_028911"
FT   VAR_SEQ         1698..1725
FT                   /note="EGLVPSSALCISHSRSSVEMDCFFPLVK -> MKGGDRAYTRGPSLGWLFAK
FT                   CCCCFPCR (in isoform 4 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:10023074"
FT                   /id="VSP_028912"
FT   VAR_SEQ         1857..1888
FT                   /note="Missing (in isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005"
FT                   /id="VSP_028913"
FT   VAR_SEQ         2314
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005"
FT                   /id="VSP_028914"
FT   VAR_SEQ         2399..2986
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005"
FT                   /id="VSP_028915"
FT   VARIANT         196
FT                   /note="S -> L"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041898"
FT   VARIANT         213
FT                   /note="R -> W (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs1187034389)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035976"
FT   VARIANT         1326
FT                   /note="E -> D (in dbSNP:rs2289838)"
FT                   /id="VAR_020192"
FT   VARIANT         1897
FT                   /note="S -> C (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035625"
FT   VARIANT         1930
FT                   /note="R -> M (in dbSNP:rs35298864)"
FT                   /id="VAR_057190"
FT   MUTAGEN         2713
FT                   /note="K->A: Loss of autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:10023074"
FT   CONFLICT        2459
FT                   /note="E -> G (in Ref. 2; BAA76314)"
FT                   /evidence="ECO:0000305"
FT   HELIX           1281..1305
FT                   /evidence="ECO:0007829|PDB:5QQJ"
FT   HELIX           1307..1313
FT                   /evidence="ECO:0007829|PDB:5QQJ"
FT   STRAND          1314..1316
FT                   /evidence="ECO:0007829|PDB:5QQJ"
FT   TURN            1320..1324
FT                   /evidence="ECO:0007829|PDB:5QQJ"
FT   HELIX           1326..1330
FT                   /evidence="ECO:0007829|PDB:5QQJ"
FT   HELIX           1333..1342
FT                   /evidence="ECO:0007829|PDB:5QQJ"
FT   HELIX           1344..1350
FT                   /evidence="ECO:0007829|PDB:5QQJ"
FT   TURN            1351..1353
FT                   /evidence="ECO:0007829|PDB:5QQJ"
FT   HELIX           1355..1358
FT                   /evidence="ECO:0007829|PDB:5QQJ"
FT   HELIX           1359..1364
FT                   /evidence="ECO:0007829|PDB:5QQJ"
FT   TURN            1365..1367
FT                   /evidence="ECO:0007829|PDB:5QQJ"
FT   HELIX           1368..1370
FT                   /evidence="ECO:0007829|PDB:5QQJ"
FT   HELIX           1371..1389
FT                   /evidence="ECO:0007829|PDB:5QQJ"
FT   HELIX           1393..1401
FT                   /evidence="ECO:0007829|PDB:5QQJ"
FT   HELIX           1407..1429
FT                   /evidence="ECO:0007829|PDB:5QQJ"
FT   HELIX           1437..1455
FT                   /evidence="ECO:0007829|PDB:5QQJ"
SQ   SEQUENCE   2986 AA;  340261 MW;  EA7B559A9E4AFFA0 CRC64;
     MTDRFWDQWY LWYLRLLRLL DRGSFRNDGL KASDVLPILK EKVAFVSGGR DKRGGPILTF
     PARSNHDRIR QEDLRKLVTY LASVPSEDVC KRGFTVIIDM RGSKWDLIKP LLKTLQEAFP
     AEIHVALIIK PDNFWQKQKT NFGSSKFIFE TSMVSVEGLT KLVDPSQLTE EFDGSLDYNH
     EEWIELRLSL EEFFNSAVHL LSRLEDLQEM LARKEFPVDV EGSRRLIDEH TQLKKKVLKA
     PVEELDREGQ RLLQCIRCSD GFSGRNCIPG SADFQSLVPK ITSLLDKLHS TRQHLHQMWH
     VRKLKLDQCF QLRLFEQDAE KMFDWISHNK ELFLQSHTEI GVSYQYALDL QTQHNHFAMN
     SMNAYVNINR IMSVASRLSE AGHYASQQIK QISTQLDQEW KSFAAALDER STILAMSAVF
     HQKAEQFLSG VDAWCKMCSE GGLPSEMQDL ELAIHHHQTL YEQVTQAYTE VSQDGKALLD
     VLQRPLSPGN SESLTATANY SKAVHQVLDV VHEVLHHQRR LESIWQHRKV RLHQRLQLCV
     FQQDVQQVLD WIENHGEAFL SKHTGVGKSL HRARALQKRH DDFEEVAQNT YTNADKLLEA
     AEQLAQTGEC DPEEIYKAAR HLEVRIQDFV RRVEQRKLLL DMSVSFHTHT KELWTWMEDL
     QKEMLEDVCA DSVDAVQELI KQFQQQQTAT LDATLNVIKE GEDLIQQLRS APPSLGEPSE
     ARDSAVSNNK TPHSSSISHI ESVLQQLDDA QVQMEELFHE RKIKLDIFLQ LRIFEQYTIE
     VTAELDAWNE DLLRQMNDFN TEDLTLAEQR LQRHTERKLA MNNMTFEVIQ QGQDLHQYIT
     EVQASGIELI CEKDIDLAAQ VQELLEFLHE KQHELELNAE QTHKRLEQCL QLRHLQAEVK
     QVLGWIRNGE SMLNASLVNA SSLSEAEQLQ REHEQFQLAI ESLFHATSLQ KTHQSALQVQ
     QKAEVLLQAG HYDADAIREC AEKVALHWQQ LMLKMEDRLK LVNASVAFYK TSEQVCSVLE
     SLEQEYRRDE DWCGGRDKLG PAAEIDHVIP LISKHLEQKE AFLKACTLAR RNAEVFLKYI
     HRNNVSMPSV ASHTRGPEQQ VKAILSELLQ RENRVLHFWT LKKRRLDQCQ QYVVFERSAK
     QALDWIQETG EFYLSTHTST GETTEETQEL LKEYGEFRVP AKQTKEKVKL LIQLADSFVE
     KGHIHATEIR KWVTTVDKHY RDFSLRMGKY RYSLEKALGV NTEDNKDLEL DIIPASLSDR
     EVKLRDANHE VNEEKRKSAR KKEFIMAELL QTEKAYVRDL HECLETYLWE MTSGVEEIPP
     GILNKEHIIF GNIQEIYDFH NNIFLKELEK YEQLPEDVGH CFVTWADKFQ MYVTYCKNKP
     DSNQLILEHA GTFFDEIQQR HGLANSISSY LIKPVQRITK YQLLLKELLT CCEEGKGELK
     DGLEVMLSVP KKANDAMHVS MLEGFDENLD VQGELILQDA FQVWDPKSLI RKGRERHLFL
     FEISLVFSKE IKDSSGHTKY VYKNKLLTSE LGVTEHVEGD PCKFALWSGR TPSSDNKTVL
     KASNIETKQE WIKNIREVIQ ERIIHLKGAL KEPLQLPKTP AKQRNNSKRD GVEDIDSQGD
     GSSQPDTISI ASRTSQNTVD SDKLSGGCEL TVVLQDFSAG HSSELTIQVG QTVELLERPS
     ERPGWCLVRT TERSPPLEGL VPSSALCISH SRSSVEMDCF FPLVKDAYSH SSSENGGKSE
     SVANLQAQPS LNSIHSSPGP KRSTNTLKKW LTSPVRRLNS GKADGNIKKQ KKVRDGRKSF
     DLGSPKPGDE TTPQGDSADE KSKKGWGEDE PDEESHTPLP PPMKIFDNDP TQDEMSSSLL
     AARQASTEVP TAADLVNAIE KLVKNKLSLE GSSYRGSLKD PAGCLNEGMA PPTPPKNPEE
     EQKAKALRGR MFVLNELVQT EKDYVKDLGI VVEGFMKRIE EKGVPEDMRG KDKIVFGNIH
     QIYDWHKDFF LAELEKCIQE QDRLAQLFIK HERKLHIYVW YCQNKPRSEY IVAEYDAYFE
     EVKQEINQRL TLSDFLIKPI QRITKYQLLL KDFLRYSEKA GLECSDIEKA VELMCLVPKR
     CNDMMNLGRL QGFEGTLTAQ GKLLQQDTFY VIELDAGMQS RTKERRVFLF EQIVIFSELL
     RKGSLTPGYM FKRSIKMNYL VLEENVDNDP CKFALMNRET SERVVLQAAN ADIQQAWVQD
     INQVLETQRD FLNALQSPIE YQRKERSTAV MRSQPARLPQ ASPRPYSSVP AGSEKPPKGS
     SYNPPLPPLK ISTSNGSPGF EYHQPGDKFE ASKQNDLGGC NGTSSMAVIK DYYALKENEI
     CVSQGEVVQV LAVNQQNMCL VYQPASDHSP AAEGWVPGSI LAPLTKATAA ESSDGSIKKS
     CSWHTLRMRK RAEVENTGKN EATGPRKPKD ILGNKVSVKE TNSSEESECD DLDPNTSMEI
     LNPNFIQEVA PEFLVPLVDV TCLLGDTVIL QCKVCGRPKP TITWKGPDQN ILDTDNSSAT
     YTVSSCDSGE ITLKICNLMP QDSGIYTCIA TNDHGTTSTS ATVKVQGVPA APNRPIAQER
     SCTSVILRWL PPSSTGNCTI SGYTVEYREE GSQIWQQSVA STLDTYLVIE DLSPGCPYQF
     RVSASNPWGI SLPSEPSEFV RLPEYDAAAD GATISWKENF DSAYTELNEI GRGRFSIVKK
     CIHKATRKDV AVKFVSKKMK KKEQAAHEAA LLQHLQHPQY ITLHDTYESP TSYILILELM
     DDGRLLDYLM NHDELMEEKV AFYIRDIMEA LQYLHNCRVA HLDIKPENLL IDLRIPVPRV
     KLIDLEDAVQ ISGHFHIHHL LGNPEFAAPE VIQGIPVSLG TDIWSIGVLT YVMLSGVSPF
     LDESKEETCI NVCRVDFSFP HEYFCGVSNA ARDFINVILQ EDFRRRPTAA TCLQHPWLQP
     HNGSYSKIPL DTSRLACFIE RRKHQNDVRP IPNVKSYIVN RVNQGT
//
